Assertio Holdings Inc (ASRT)
1.01
0.00 (0.00%)
USD |
NASDAQ |
May 15, 15:55
Assertio Holdings Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | -0.239M |
| September 30, 2023 | 4.144M |
| June 30, 2023 | -0.703M |
| March 31, 2023 | -0.105M |
| December 31, 2022 | -25.78M |
| September 30, 2022 | -0.371M |
| June 30, 2022 | -16.11M |
| March 31, 2022 | -0.404M |
| December 31, 2021 | -18.52M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.001M |
| June 30, 2020 | 63.77M |
| March 31, 2020 | 449.04M |
| December 31, 2019 | 0.045M |
| September 30, 2019 | 6.209M |
| June 30, 2019 | -7.722M |
| March 31, 2019 | -0.013M |
| December 31, 2018 | -1.52M |
| September 30, 2018 | -6.215M |
| June 30, 2018 | -0.771M |
| March 31, 2018 | 1.424M |
| Date | Value |
|---|---|
| December 31, 2017 | 4.569M |
| September 30, 2017 | -2.341M |
| June 30, 2017 | 3.255M |
| March 31, 2017 | 52.41M |
| December 31, 2016 | -13.03M |
| September 30, 2016 | -16.03M |
| June 30, 2016 | -21.24M |
| March 31, 2016 | 95.84M |
| December 31, 2015 | -67.24M |
| September 30, 2015 | -38.67M |
| June 30, 2015 | -564.33M |
| March 31, 2015 | -437.80M |
| December 31, 2014 | -64.60M |
| September 30, 2014 | -0.507M |
| June 30, 2014 | 4.983M |
| March 31, 2014 | 12.81M |
| December 31, 2013 | -60.56M |
| September 30, 2013 | 4.042M |
| June 30, 2013 | 21.17M |
| March 31, 2013 | -2.686M |
| December 31, 2012 | 6.621M |
| September 30, 2012 | 13.81M |
| June 30, 2012 | -14.31M |
| March 31, 2012 | 27.22M |
| December 31, 2011 | 18.40M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.78M
Minimum
Dec 2022
449.04M
Maximum
Mar 2020
22.66M
Average
-0.0005M
Median
Cash from Investing (Quarterly) Benchmarks
| Ocular Therapeutix Inc | -0.255M |
| Vertex Pharmaceuticals Inc | -2.136B |
| Cormedix Inc | 8.945M |
| Verastem Inc | 30.98M |
| CytomX Therapeutics Inc | 44.88M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.508M |
| Cash from Financing (Quarterly) | -0.206M |
| Free Cash Flow | 34.40M |
| Free Cash Flow Per Share (Quarterly) | 0.079 |
| Free Cash Flow to Equity (Quarterly) | 7.401M |
| Free Cash Flow to Firm (Quarterly) | 8.288M |
| Free Cash Flow Yield | 39.86% |